YaoGeJu

Company directoryChina company filings

Xiangbei Welman Pharmaceutical Co., Ltd.

As of 18 November 2026, for the company name Xiangbei Welman Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 31 active records with this name as holder; 12 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

55 acceptance records as first applicant, grouped into 19 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Baloxavir Marboxil Tablets 2 records · Latest accepted 2026/06/04

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601297Generic2026/06/04Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHS2601296Generic2026/06/04Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
Piperacillin Sodium And Tazobactam Sodium For Injection 3 records · Latest accepted 2026/06/01

Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2601040Supplement2026/06/01Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2550126Supplement2025/02/26Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2550125Supplement2025/02/26Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
Sildenafil Citrate Tablets 3 records · Latest accepted 2025/08/28

Generic · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503156Generic2025/08/28Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHS2503155Generic2025/08/28Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHS2500190Generic2025/01/09Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
Levofloxacin Tablets 2 records · Latest accepted 2025/08/23

Supplement · 1Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2501678Supplement2025/08/23Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHS2101867Generic2021/10/14Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
F-02-2-Na片 · No verified English name 1 records · Latest accepted 2025/06/18

New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2500587New drug2025/06/18Xiangbei Welman Pharmaceutical Co., Ltd.; Guangzhou Xin Chuang Yi Biopharmaceuticals Co., Ltd. romanized; Guangdong Heng Qin Xin Chuang Yi Biopharmaceuticals Co., Ltd. romanizedCDE ↗
注射用头孢噻肟钠他唑巴坦钠 · No verified English name 5 records · Latest accepted 2025/02/19

Supplement · 3Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2500332Supplement2025/02/19Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2500331Supplement2025/02/19Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2402034Supplement2024/11/30Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHS2200903Generic2022/06/16Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHS2200902Generic2022/06/16Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
Dapoxetine Hydrochloride Tablets 2 records · Latest accepted 2024/08/30

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402849Generic2024/08/30Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHS2402848Generic2024/08/30Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
Cefoperazone Sodium and Sulbactam Sodium for Injection 8 records · Latest accepted 2024/08/09

Generic · 3Supplement · 5

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402584Generic2024/08/09Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHS2402583Generic2024/08/09Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHS2402582Generic2024/08/09Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2450364Supplement2024/07/08Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2450363Supplement2024/07/08Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2450362Supplement2024/07/08Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2450361Supplement2024/07/08Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2450360Supplement2024/07/08Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
Ceftazidime And Avibactam Sodium For Injection 1 records · Latest accepted 2024/08/02

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402452Generic2024/08/02Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
Cefotaxime Sodium For Injection 5 records · Latest accepted 2024/05/31

Supplement · 5

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450311Supplement2024/05/31Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2450310Supplement2024/05/31Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2450309Supplement2024/05/31Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2450308Supplement2024/05/31Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2450307Supplement2024/05/31Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
Tadalafil Tablets 4 records · Latest accepted 2024/03/15

Generic · 4

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2400852Generic2024/03/15Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHS2400851Generic2024/03/15Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHS2400850Generic2024/03/15Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHS2301655Generic2023/06/19Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
Acetylcysteine Granules 2 records · Latest accepted 2024/02/21

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2400660Generic2024/02/21Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHS2400659Generic2024/02/21Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
注射用头孢噻肟钠舒巴坦钠 · No verified English name 6 records · Latest accepted 2023/12/16

Supplement · 6

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2302747Supplement2023/12/16Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2302746Supplement2023/12/16Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2302745Supplement2023/12/16Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2302744Supplement2023/12/16Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2200183Supplement2022/01/21Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2200182Supplement2022/01/21Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
注射用头孢曲松钠舒巴坦钠 · No verified English name 4 records · Latest accepted 2023/12/12

Supplement · 4

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2302706Supplement2023/12/12Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2302705Supplement2023/12/12Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2302704Supplement2023/12/12Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2200177Supplement2022/01/21Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
莫达非尼胶囊 · No verified English name 2 records · Latest accepted 2023/09/02

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350668Supplement2023/09/02Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2350667Supplement2023/09/02Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
Amoxicillin and Clavulanate Potassium Tablets 1 records · Latest accepted 2023/06/28

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350504Supplement2023/06/28Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
Sevelamer Carbonate Tablets 1 records · Latest accepted 2022/08/23

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201351Generic2022/08/23Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
注射用哌拉西林钠舒巴坦钠 · No verified English name 2 records · Latest accepted 2022/01/21

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2200181Supplement2022/01/21Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
CYHB2200180Supplement2022/01/21Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
注射用头孢哌酮钠他唑巴坦钠 · No verified English name 1 records · Latest accepted 2022/01/21

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2200179Supplement2022/01/21Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗

Changes in the last 90 days

0 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

  1. No matching records were found in the currently loaded source data; coverage dates are listed below.

Under review

4 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Baloxavir Marboxil Tablets CYHS2601297Generic2026/06/04Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
Baloxavir Marboxil Tablets CYHS2601296Generic2026/06/04Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
Sildenafil Citrate Tablets CYHS2503156Generic2025/08/28Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
Sildenafil Citrate Tablets CYHS2503155Generic2025/08/28Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗

Catalogue holder records

31 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Piperacillin Sodium And Tazobactam Sodium For InjectionXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H202692222026/09/01Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Sildenafil Citrate TabletsXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H202651552026/07/14Generic approved under the new chemical-drug registration classificationCDE ↗
Piperacillin Sodium And Tazobactam Sodium For InjectionXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H200735992026/04/10Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Piperacillin Sodium And Tazobactam Sodium For InjectionXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H200735972026/04/10Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Ceftazidime And Avibactam Sodium For InjectionXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H202631912026/01/27Generic approved under the new chemical-drug registration classificationCDE ↗
Cefoperazone Sodium and Sulbactam Sodium for InjectionXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H202632112026/01/27Generic approved under the new chemical-drug registration classificationCDE ↗
Cefoperazone Sodium and Sulbactam Sodium for InjectionXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H202632122026/01/27Generic approved under the new chemical-drug registration classificationCDE ↗
Cefoperazone Sodium and Sulbactam Sodium for InjectionXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H202632132026/01/27Generic approved under the new chemical-drug registration classificationCDE ↗
Dapoxetine Hydrochloride TabletsXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H202560022025/11/18Generic approved under the new chemical-drug registration classificationCDE ↗
Sevelamer Carbonate TabletsXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H202559152025/11/12Generic approved under the new chemical-drug registration classificationCDE ↗
Cefoperazone Sodium and Sulbactam Sodium for InjectionXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H200339622025/08/25Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefoperazone Sodium and Sulbactam Sodium for InjectionXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H202581692025/08/25Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefoperazone Sodium and Sulbactam Sodium for InjectionXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H200339612025/08/25Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefoperazone Sodium and Sulbactam Sodium for InjectionXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H200236872025/08/25Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefoperazone Sodium and Sulbactam Sodium for InjectionXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H200131122025/08/25Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefotaxime Sodium For InjectionXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H200341392025/08/07Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefotaxime Sodium For InjectionXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H202581572025/08/07Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefotaxime Sodium For InjectionXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H430203882025/08/07Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefotaxime Sodium For InjectionXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H430203862025/08/07Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefotaxime Sodium For InjectionXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H200338942025/08/07Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Tadalafil TabletsXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H202549182025/07/22Generic approved under the new chemical-drug registration classificationCDE ↗
Tadalafil TabletsXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H202549162025/07/22Generic approved under the new chemical-drug registration classificationCDE ↗
Acetylcysteine GranulesXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H202542172025/05/20Not stated by sourceCDE ↗
Acetylcysteine GranulesXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H202542182025/05/20Generic approved under the new chemical-drug registration classificationCDE ↗
Tadalafil TabletsXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H202491492024/10/22Generic approved under the new chemical-drug registration classificationCDE ↗
Amoxicillin and Clavulanate Potassium TabletsXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H200304612024/08/09Drug that passed quality-and-efficacy consistency evaluationCDE ↗
莫达非尼胶囊 · No verified English nameXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H201700142024/08/01Drug that passed quality-and-efficacy consistency evaluationCDE ↗
莫达非尼胶囊 · No verified English nameXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H201700132024/08/01Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Levofloxacin TabletsXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H202340682023/08/29Generic approved under the new chemical-drug registration classificationCDE ↗
Amoxicillin and Clavulanate Potassium TabletsXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H200517102021/08/20Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Tadalafil TabletsXiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.国药准字H202549172025/07/22Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

12 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
他唑巴坦钠 · No verified English nameXiangbei Welman Pharmaceutical Co., Ltd.Y20260000491I2026/07/01CDE ↗
右莰醇 · No verified English nameXiangbei Welman Pharmaceutical Co., Ltd.Y20260000240I2026/03/31CDE ↗
玛巴洛沙韦 · No verified English nameXiangbei Welman Pharmaceutical Co., Ltd.Y20260000150I2026/03/10CDE ↗
磷酸芦可替尼 · No verified English nameXiangbei Welman Pharmaceutical Co., Ltd.Y20260000039I2026/02/09CDE ↗
盐酸埃克替尼 · No verified English nameXiangbei Welman Pharmaceutical Co., Ltd.Y20250001237I2025/11/24CDE ↗
哌拉西林钠 · No verified English nameXiangbei Welman Pharmaceutical Co., Ltd.Y20250001050I2025/10/15CDE ↗
多司马酯 · No verified English nameXiangbei Welman Pharmaceutical Co., Ltd.Y20250000307I2025/04/07CDE ↗
艾普拉唑 · No verified English nameXiangbei Welman Pharmaceutical Co., Ltd.Y20240001539A2026/07/13CDE ↗
马来酸阿伐曲泊帕 · No verified English nameXiangbei Welman Pharmaceutical Co., Ltd.Y20230001084A2025/07/14CDE ↗
他达拉非 · No verified English nameXiangbei Welman Pharmaceutical Co., Ltd.Y20220001003A2026/04/14CDE ↗
丁苯酞 · No verified English nameXiangbei Welman Pharmaceutical Co., Ltd.Y20220000692A2024/12/27CDE ↗
莫达非尼 · No verified English nameXiangbei Welman Pharmaceutical Co., Ltd.Y20190008895A2025/06/28CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

11 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Amoxicillin Sodium and Clavulanate Potassium for Injection CYHS2601582Generic2026/07/03Guangzhou Ai Qi Xi Xin Yao Research Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
F-02-2-Na片 · No verified English name CXHL2500589New drug2025/06/18Guangdong Heng Qin Xin Chuang Yi Biopharmaceuticals Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd.; Guangzhou Xin Chuang Yi Biopharmaceuticals Co., Ltd. romanizedCDE ↗
F-02-2-Na片 · No verified English name CXHL2500588New drug2025/06/18Guangdong Heng Qin Xin Chuang Yi Biopharmaceuticals Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd.; Guangzhou Xin Chuang Yi Biopharmaceuticals Co., Ltd. romanizedCDE ↗
Amoxicillin Sodium for Injection CYHS2302386Generic2023/09/05Guangzhou Ai Qi Xi Xin Yao Research Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
Amoxicillin Sodium for Injection CYHS2302385Generic2023/09/05Guangzhou Ai Qi Xi Xin Yao Research Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
注射用头孢曲松钠舒巴坦钠 · No verified English name CYHB2102131Supplement2021/11/11Hunan Wei Er Qiang Pharmaceutical Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
注射用头孢噻肟钠舒巴坦钠 · No verified English name CYHB2102130Supplement2021/11/11Hunan Wei Er Qiang Pharmaceutical Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
注射用头孢噻肟钠舒巴坦钠 · No verified English name CYHB2102129Supplement2021/11/11Hunan Wei Er Qiang Pharmaceutical Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
注射用哌拉西林钠舒巴坦钠 · No verified English name CYHB2102128Supplement2021/11/11Hunan Wei Er Qiang Pharmaceutical Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
注射用哌拉西林钠舒巴坦钠 · No verified English name CYHB2102127Supplement2021/11/11Hunan Wei Er Qiang Pharmaceutical Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗
注射用头孢哌酮钠他唑巴坦钠 · No verified English name CYHB2102126Supplement2021/11/11Hunan Wei Er Qiang Pharmaceutical Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.